NCT04706910 2026-02-09
18F-DOPA II - PET Imaging Optimization
University of Alberta
Phase 3 Recruiting
Clinical Trials
12 trialsNCT05781321 2026-02-03
Short Course Radiotherapy for the Treatment of Patients With Glioblastoma, SAGA Study
Mayo Clinic
Phase 2 Active not recruiting
NCT07025226 2026-01-26
Senolytics
Mayo Clinic
Phase EARLY_PHASE1 Recruiting
NCT01991977 2025-10-20
18F-DOPA-PET in Finding Tumors in Patients With Newly Diagnosed Gliomas Undergoing Radiation Therapy
Mayo Clinic
Phase 2 Completed
NCT01165632 2025-09-02
Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma
Mayo Clinic
Phase EARLY_PHASE1 Completed
NCT03778294 2025-07-03
18F-DOPA-PET/MRI Scan in Imaging Elderly Patients With Newly Diagnosed Grade IV Malignant Glioma or Glioblastoma During Planning for a Short Course of Proton Beam Radiation Therapy
Mayo Clinic
Phase 2 Completed
NCT02020720 2025-01-23
18F-DOPA-PET in Planning Surgery in Patients With Gliomas
Mayo Clinic
Phase EARLY_PHASE1 Completed
NCT03242824 2023-03-14
The Utility of 18F-DOPA-PET in the Treatment of Recurrent High-grade Glioma
Mayo Clinic
Phase 2 Completed
NCT03042416 2022-01-10
18F-DOPA PET Imaging: an Evaluation of Biodistribution and Safety
University of Alberta
Phase 3 Completed
NCT04315584 2020-03-24
FDG and FDOPA PET Demonstration of Functional Brain Abnormalities
University of Virginia
Phase EARLY_PHASE1 Unknown
NCT02176720 2018-08-17
Response Monitoring Trial in Patients With Suspected Recurrence of Glioblastoma
The Methodist Hospital Research Institute
Phase 1 Terminated
NCT02371031 2016-11-30
FDOPA-PET/MRI for the Pre-operative Evaluation of Gliomas
Washington University School of Medicine
Phase 1 Terminated